You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Drugs Containing Excipient (Inactive Ingredient) AMMONIUM GLYCYRRHIZATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing AMMONIUM GLYCYRRHIZATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing AMMONIUM GLYCYRRHIZATE excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: Ammonium Glycyrrhizinate

Last updated: August 5, 2025

Introduction

Ammonium Glycyrrhizinate, an ammonium salt of glycyrrhizic acid derived from licorice root, has gained notable prominence within the pharmaceutical excipient landscape. Valued for its anti-inflammatory, hepatoprotective, and skin-conditioning properties, it serves in formulations targeting gastrointestinal, dermatological, and respiratory applications. This article evaluates the current market dynamics, growth drivers, challenges, and future financial trajectories for Ammonium Glycyrrhizinate, equipping stakeholders with strategic insights.

Market Overview

The global pharmaceutical excipients market is anticipated to surpass USD 9 billion by 2025, with natural and plant-based products increasingly preferred, reflecting consumer trends towards biocompatibility and safety [1]. Ammonium Glycyrrhizinate, positioned within this subset, benefits from burgeoning demand for plant-derived, multifunctional excipients. Its dual role as an active compound and excipient enhances its market significance, especially in herbal and natural product formulations.

Key Market Drivers

1. Rising Demand for Natural and Plant-Based Excipients

Consumer preferences tilt toward natural, minimally processed ingredients. Licorice-derived compounds, including Ammonium Glycyrrhizinate, fit neatly into this paradigm. The ingredient's natural origin aligns with clean label initiatives, propelling its adoption (Research indicates a 15% CAGR in natural excipient segments) [2].

2. Expanding Therapeutic and Cosmetic Applications

Ammonium Glycyrrhizinate's versatility extends across multiple domains—anti-inflammatory properties assist in gastrointestinal remedies, while its skin-soothing effects find favor in dermatology products. Rising consumption of herbal medicines and cosmeceuticals drives derivative demand [3].

3. Regulatory Support and Safety Profile

Regulatory agencies such as the European Medicines Agency (EMA) and U.S. FDA recognize glycyrrhizic acid derivatives for therapeutic applications. Its established safety profile reduces barriers to market entry, fostering further development. Clear regulatory pathways encourage formulators to incorporate Ammonium Glycyrrhizinate as a stabilizer or active component.

4. Innovative Formulation Advancements

Nanotechnology and controlled-release systems facilitate enhanced delivery of Ammonium Glycyrrhizinate, broadening its application spectrum. Companies investing in formulation innovation expect increased market penetration.

Market Challenges

1. Supply Chain Constraints

Dependence on licorice cultivation affects raw material availability. Geopolitical factors, climate variability, and cultivation challenges can induce supply disruptions, impacting pricing and consistency [4].

2. Standardization and Quality Control

Variability in natural sources necessitates rigorous standardization protocols. Ensuring batch-to-batch consistency remains a critical hurdle, particularly for pharmaceutical-grade excipients.

3. Competition from Synthetic Alternatives

While natural origins confer advantages, synthetic anti-inflammatory and soothing agents are often cost-effective, challenging Ammonium Glycyrrhizinate's market share in certain formulations.

4. Market Penetration Barriers

Limited awareness among formulators regarding its multifunctional benefits hampers widespread adoption beyond niche markets.

Financial Trajectory and Market Forecasts

Historical Growth Patterns

The Ammonium Glycyrrhizinate segment has exhibited robust growth in recent years, averaging a CAGR of approximately 8–10% globally, driven by natural product trends and expanding therapeutic areas [5].

Projected Growth

Forecasts predict the segment will maintain a compound annual growth rate (CAGR) of approximately 9% over the next five years. The Asia-Pacific region, particularly China and India, will lead this expansion, owing to large-scale licorice cultivation and burgeoning herbal medicine industries [6].

Revenue Streams and Key Players

Major manufacturers—such as Sabinsa Corporation, Frutarom (now part of IFF), and Megafine Chem—are investing in sustainable sourcing and innovative formulating techniques. Strategic collaborations and R&D investments aim to diversify applications, potentially increasing revenue streams significantly.

Pricing Trends

Prices for Ammonium Glycyrrhizinate fluctuate based on purity levels, source quality, and market demand. A significant upward trend is anticipated if supply chain constraints are alleviated through cultivation diversification.

Strategic Opportunities

Sustainable Sourcing and Cultivation

Vertical integration, gene editing, and expansion into new cultivation zones can secure raw material supply, stabilizing costs.

Product Innovation

Developing novel delivery systems—such as liposomes or topical patches—can expand application domains, driving premium pricing.

Regulatory Engagement

Proactive engagement with regulatory bodies can streamline approval processes, foster trust, and accelerate market entry.

Market Diversification

Targeting emerging markets within Asia and Africa, where herbal medicine acceptance grows rapidly, provides expansive opportunities.

Conclusion

Ammonium Glycyrrhizinate's market outlook remains favorable, bolstered by natural product trends, expanding application scope, and regulatory support. However, navigating supply chain complexities and stiff competition requires strategic foresight. Stakeholders investing in sustainable sourcing, innovative formulations, and regulatory partnerships will be positioned to capitalize on anticipated growth.

Key Takeaways

  • The global demand for natural, plant-derived excipients like Ammonium Glycyrrhizinate is experiencing sustained growth, driven by consumer preferences and expanding therapeutic applications.
  • Supply chain stability remains a critical challenge, necessitating strategic cultivation and sourcing initiatives.
  • The segment is projected to grow at approximately 9% CAGR over the next five years, with Asia-Pacific markets leading expansion.
  • Innovation in delivery systems and formulations presents significant revenue-growth opportunities.
  • Regulatory alignment and quality assurance are vital to gaining market trust and facilitating widespread adoption.

FAQs

1. What are the primary pharmaceutical applications of Ammonium Glycyrrhizinate?
It is used as an anti-inflammatory agent, skin soother in dermatological products, and in formulations for gastrointestinal relief due to its hepatoprotective and demulcent properties.

2. How does the natural origin of Ammonium Glycyrrhizinate influence its market?
Its natural derivation aligns with consumer demand for clean, sustainable ingredients, giving it a competitive edge in herbal and organic formulations.

3. What are the main risks impacting its market growth?
Supply chain disruptions, quality standardization issues, competition from synthetic alternatives, and regulatory hurdles pose significant risks.

4. Which regions are expected to see the highest growth for Ammonium Glycyrrhizinate?
The Asia-Pacific region is forecasted to lead growth, supported by large-scale licorice cultivation and rising herbal product consumption.

5. What strategies can companies adopt to maximize their market share?
Investing in sustainable sourcing, formulation innovation, regulatory engagement, and expanding into emerging markets can enhance market positioning.


References

[1] MarketsandMarkets. "Pharmaceutical Excipients Market by Type, Functionality, Source, Application, and Region," 2020.
[2] Future Market Insights. "Natural Excipients Market Outlook," 2021.
[3] Grand View Research. "Herbal and Phytochemicals Market Trends," 2022.
[4] FAO. "Licorice Production and Supply Risks," 2022.
[5] Allied Market Research. "Anti-inflammatory and Skin-care Ingredients Market," 2022.
[6] Research and Markets. "Asia-Pacific Herbal Medicine Market Analysis," 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.